A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi
Clinical trial NCT05385068 · UNKNOWN
Trial details
- NCT number
- NCT05385068
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.